Stay updated on Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Sign up to get notified when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Locations sections were consolidated under a single 'Locations' header and now list California, District of Columbia, Illinois, Missouri, New York, and Texas; the HHS Vulnerability Disclosure link was removed and the page revision updated to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-23T10:18:06.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    The page shows a minor revision update: Revision: v3.3.2 was added and Revision: v3.3.1 was removed; core study details, eligibility criteria, endpoints, and results remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:39:10.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page now displays a new revision note: Revision: v3.3.1, replacing the previous v3.2.0, while the core study details and eligibility information appear unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:41:25.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    Removed a generic notice about funding-related outages and the NIH Clinical Center's operating status from the page. The study content and eligibility details remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-17T06:52:27.000Z thumbnail image
  8. Check
    70 days ago
    Change Detected
    Summary
    No additions or deletions were detected; the page content remains unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T01:18:02.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    Major change: version bump to v3.2.0 and an important operating-status notice about government funding and NIH Clinical Center, directing users to official sources.
    Difference
    3%
    Check dated 2025-10-05T10:07:14.000Z thumbnail image

Stay in the know with updates to Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ipilimumab/Nivolumab in High-Risk Ocular Melanoma Clinical Trial page.